AMRS Amyris, Inc.

3.72-0.05 (-1.33%)
Close: November 21, 2019

Quote

Previous Close
$3.72
Day Range
$3.62-$3.79
52 Week Range
$1.87-$6.06
Volume
707,253
Avg Volume
692,372
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$392.47M
Enterprise Value (EV)
$561.54M
PE Ratio
-
EV/EBITDA
-4.39
Price/Sales
6.25
Price/Book
-
PEG Ratio
-

Financials

Revenue
$63.60M
Gross Profit
$26.91M
EBITDA
-$127.80M
EPS, ttm
-$2.86
Profit Margin
-
Revenue/Employee
$126.45K
Next Earnings Date
3/3/2020 (102 days)
Debt to Equity
-99%
Debt
$215.17M
Cash
$46.09M
Net Debt
$169.07M

Performance

Beta
1.78
200 Day Moving Avg
$3.89
50 Day Moving Avg
$4.07
52 Week Change
-4.07%
YTD Change
-1.59%
1 Month Change
-0.79%
3 Month Change
-12.73%
6 Month Change
-8.50%
1 Year Change
-4.07%
2 Year Change
2.45%
5 Year Change
-91.42%

Share Count

Shares Outstanding
105.5M
Float
54.0M
Restricted Shares
51.5M
Restricted Shares, %
48.79%

Amyris, Inc. Company Details

Sector: Process Industries

Industry: Chemicals: Specialty

CEO: John G. Melo

Website: http://www.amyris.com

Description: Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Employees: 503